162 related articles for article (PubMed ID: 34779644)
1. FTO demethylates YAP mRNA promoting oral squamous cell carcinoma tumorigenesis.
Li DQ; Huang CC; Zhang G; Zhou LL
Neoplasma; 2022 Jan; 69(1):71-79. PubMed ID: 34779644
[TBL] [Abstract][Full Text] [Related]
2. Fat mass and obesity-associated protein regulates tumorigenesis of arecoline-promoted human oral carcinoma.
Li X; Xie X; Gu Y; Zhang J; Song J; Cheng X; Gao Y; Ai Y
Cancer Med; 2021 Sep; 10(18):6402-6415. PubMed ID: 34378866
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma.
Wang F; Liao Y; Zhang M; Zhu Y; Wang W; Cai H; Liang J; Song F; Hou C; Huang S; Zhang Y; Wang C; Hou J
Oncogene; 2021 Jun; 40(22):3885-3898. PubMed ID: 33972683
[TBL] [Abstract][Full Text] [Related]
4. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
5. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
6. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
8. The m
Romanowska K; Rawłuszko-Wieczorek AA; Marczak Ł; Kosińska A; Suchorska WM; Golusiński W
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207099
[TBL] [Abstract][Full Text] [Related]
9. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
10. Dynamic m6A modification regulates local translation of mRNA in axons.
Yu J; Chen M; Huang H; Zhu J; Song H; Zhu J; Park J; Ji SJ
Nucleic Acids Res; 2018 Feb; 46(3):1412-1423. PubMed ID: 29186567
[TBL] [Abstract][Full Text] [Related]
11. Decreased
Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
[TBL] [Abstract][Full Text] [Related]
12. The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.
Li J; Han Y; Zhang H; Qian Z; Jia W; Gao Y; Zheng H; Li B
Biochem Biophys Res Commun; 2019 May; 512(3):479-485. PubMed ID: 30905413
[TBL] [Abstract][Full Text] [Related]
13. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
[TBL] [Abstract][Full Text] [Related]
14. m
Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
[TBL] [Abstract][Full Text] [Related]
15. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
16. FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation.
Zhou S; Bai ZL; Xia D; Zhao ZJ; Zhao R; Wang YY; Zhe H
Mol Carcinog; 2018 May; 57(5):590-597. PubMed ID: 29315835
[TBL] [Abstract][Full Text] [Related]
17. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3.
Xie W; Shao Y; Bo Q; Li Z; Yu Q; Wang L; Wu G
Mol Carcinog; 2024 May; 63(5):926-937. PubMed ID: 38380957
[TBL] [Abstract][Full Text] [Related]
18. FTO Demethylates Cyclin D1 mRNA and Controls Cell-Cycle Progression.
Hirayama M; Wei FY; Chujo T; Oki S; Yakita M; Kobayashi D; Araki N; Takahashi N; Yoshida R; Nakayama H; Tomizawa K
Cell Rep; 2020 Apr; 31(1):107464. PubMed ID: 32268083
[TBL] [Abstract][Full Text] [Related]
19. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine demethylase FTO regulates synaptic and cognitive impairment by destabilizing PTEN mRNA in hypoxic-ischemic neonatal rats.
Deng J; Liao Y; Chen J; Chen A; Wu S; Huang Y; Qian H; Gao F; Wu G; Chen Y; Chen X; Zheng X
Cell Death Dis; 2023 Dec; 14(12):820. PubMed ID: 38092760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
